Hematopoietic reconstitution dynamics of mobilized- and bone marrow-derived human hematopoietic stem cells after gene therapy.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
27 05 2023
Historique:
received: 08 08 2022
accepted: 28 04 2023
medline: 29 5 2023
pubmed: 28 5 2023
entrez: 27 5 2023
Statut: epublish

Résumé

Mobilized peripheral blood is increasingly used instead of bone marrow as a source of autologous hematopoietic stem/progenitor cells for ex vivo gene therapy. Here, we present an unplanned exploratory analysis evaluating the hematopoietic reconstitution kinetics, engraftment and clonality in 13 pediatric Wiskott-Aldrich syndrome patients treated with autologous lentiviral-vector transduced hematopoietic stem/progenitor cells derived from mobilized peripheral blood (n = 7), bone marrow (n = 5) or the combination of the two sources (n = 1). 8 out of 13 gene therapy patients were enrolled in an open-label, non-randomized, phase 1/2 clinical study (NCT01515462) and the remaining 5 patients were treated under expanded access programs. Although mobilized peripheral blood- and bone marrow- hematopoietic stem/progenitor cells display similar capability of being gene-corrected, maintaining the engineered grafts up to 3 years after gene therapy, mobilized peripheral blood-gene therapy group shows faster neutrophil and platelet recovery, higher number of engrafted clones and increased gene correction in the myeloid lineage which correlate with higher amount of primitive and myeloid progenitors contained in hematopoietic stem/progenitor cells derived from mobilized peripheral blood. In vitro differentiation and transplantation studies in mice confirm that primitive hematopoietic stem/progenitor cells from both sources have comparable engraftment and multilineage differentiation potential. Altogether, our analyses reveal that the differential behavior after gene therapy of hematopoietic stem/progenitor cells derived from either bone marrow or mobilized peripheral blood is mainly due to the distinct cell composition rather than functional differences of the infused cell products, providing new frames of references for clinical interpretation of hematopoietic stem/progenitor cell transplantation outcome.

Identifiants

pubmed: 37244942
doi: 10.1038/s41467-023-38448-y
pii: 10.1038/s41467-023-38448-y
pmc: PMC10224916
doi:

Substances chimiques

Granulocyte Colony-Stimulating Factor 143011-72-7

Banques de données

ClinicalTrials.gov
['NCT01515462']

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3068

Informations de copyright

© 2023. The Author(s).

Références

Stem Cell Reports. 2017 Apr 11;8(4):977-990
pubmed: 28330619
Ann N Y Acad Sci. 2013 May;1285:26-43
pubmed: 23527602
Blood Cancer J. 2016 Jul 01;6(7):e441
pubmed: 27367478
Am J Blood Res. 2021 Oct 15;11(5):544-563
pubmed: 34824887
Haematologica. 2017 Apr;102(4):e120-e124
pubmed: 28034992
Exp Hematol. 2001 Apr;29(4):525-33
pubmed: 11301193
Hematol Oncol Clin North Am. 2017 Oct;31(5):721-735
pubmed: 28895843
Sci Transl Med. 2022 Jul 13;14(653):eabl4106
pubmed: 35857642
Genome Med. 2014 Jun 27;6(6):46
pubmed: 25028597
Nat Med. 2018 Nov;24(11):1683-1690
pubmed: 30275570
Sci Rep. 2022 Mar 9;12(1):3836
pubmed: 35264585
Blood. 2000 Jan 1;95(1):102-10
pubmed: 10607692
Sci Transl Med. 2014 Jan 1;6(217):217ra3
pubmed: 24382895
Mol Ther. 2018 Mar 7;26(3):917-931
pubmed: 29433935
Nat Med. 2022 Jan;28(1):71-80
pubmed: 35075289
Haematologica. 2018 May;103(5):778-786
pubmed: 29472357
Cell Stem Cell. 2014 Apr 3;14(4):473-85
pubmed: 24702996
BMC Bioinformatics. 2017 Nov 25;18(1):520
pubmed: 29178837
Nat Commun. 2022 Mar 14;13(1):1315
pubmed: 35288539
Mol Ther Methods Clin Dev. 2021 Jun 01;22:76-83
pubmed: 34485596
Am J Hematol. 2020 Sep;95(9):E239-E242
pubmed: 32401372
Hum Genet. 2020 Mar;139(3):309-331
pubmed: 31324975
Blood. 2017 Mar 16;129(11):1448-1457
pubmed: 28087539
Cytometry A. 2017 Oct;91(10):952-965
pubmed: 28609016
N Engl J Med. 2018 Apr 19;378(16):1479-1493
pubmed: 29669226
Lancet. 2022 Jan 22;399(10322):372-383
pubmed: 35065785
Blood. 2020 Apr 9;135(15):1219-1231
pubmed: 32040546
Lancet Haematol. 2019 May;6(5):e239-e253
pubmed: 30981783
Nat Med. 2021 Aug;27(8):1458-1470
pubmed: 34140705
Science. 2018 Jan 12;359(6372):
pubmed: 29326244
Stem Cell Reports. 2016 Oct 11;7(4):591-601
pubmed: 27618723
Blood. 2010 Jun 3;115(22):4356-66
pubmed: 20228274
Science. 2013 Aug 23;341(6148):1233151
pubmed: 23845947
N Engl J Med. 2014 Jul 31;371(5):434-46
pubmed: 25075835
Nat Med. 2019 Feb;25(2):234-241
pubmed: 30664781
Blood. 2009 Jun 18;113(25):6288-95
pubmed: 19351959
Transfus Apher Sci. 2018 Apr;57(2):168-170
pubmed: 29764770
J Exp Med. 2005 Apr 18;201(8):1307-18
pubmed: 15837815
Blood Adv. 2019 Jun 25;3(12):1916-1924
pubmed: 31239246
Front Microbiol. 2019 Jun 12;10:1277
pubmed: 31244801
Front Pediatr. 2019 Oct 31;7:443
pubmed: 31737588
Science. 2013 Aug 23;341(6148):1233158
pubmed: 23845948
Cell Stem Cell. 2016 Jul 7;19(1):107-19
pubmed: 27237736
Transplantation. 2005 Oct 15;80(7):969-76
pubmed: 16249747
Blood. 1996 Feb 15;87(4):1644-53
pubmed: 8608259
Oncoimmunology. 2014 Apr 29;3:e28696
pubmed: 25097805
Biol Blood Marrow Transplant. 2017 Aug;23(8):1241-1249
pubmed: 28495640
Blood. 1997 Oct 1;90(7):2680-9
pubmed: 9326235
N Engl J Med. 2021 Nov 18;385(21):1929-1940
pubmed: 34788506
Nat Med. 2019 Sep;25(9):1396-1401
pubmed: 31501599
Nat Med. 2003 Apr;9(4):463-8
pubmed: 12640448
Curr Gene Ther. 2016;16(3):184-93
pubmed: 27121108
Cell Stem Cell. 2014 Apr 3;14(4):486-499
pubmed: 24702997
Blood. 2002 Mar 15;99(6):2037-44
pubmed: 11877277
Blood. 2001 Nov 15;98(10):2900-8
pubmed: 11698269
Pediatr Blood Cancer. 2015 Aug;62(8):1477-80
pubmed: 25755177
N Engl J Med. 2017 Oct 26;377(17):1630-1638
pubmed: 28976817
Biol Blood Marrow Transplant. 2018 Nov;24(11):2171-2177
pubmed: 29935214
Nat Rev Mol Cell Biol. 2021 Feb;22(2):75-95
pubmed: 33328614
Cell Stem Cell. 2014 Aug 7;15(2):227-38
pubmed: 25017720
Blood Adv. 2019 Aug 13;3(15):2250-2263
pubmed: 31345792
Nat Rev Genet. 2021 Apr;22(4):216-234
pubmed: 33303992

Auteurs

Serena Scala (S)

San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.

Francesca Ferrua (F)

San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.
Pediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.

Luca Basso-Ricci (L)

San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.

Francesca Dionisio (F)

San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.

Maryam Omrani (M)

San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.
Department of Computer Science, Systems and Communication, University of Milano Bicocca, Milan, 20126, Italy.

Pamela Quaranta (P)

San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.
Università Vita-Salute San Raffaele, Milan, 20132, Italy.

Raisa Jofra Hernandez (R)

San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.

Luca Del Core (L)

San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.
University of Groningen - Bernoulli Institute for Mathematics, Computer Science and Artificial Intelligence, Groningen, 9747, Netherlands.

Fabrizio Benedicenti (F)

San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.

Ilaria Monti (I)

San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.

Stefania Giannelli (S)

San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.

Federico Fraschetta (F)

Pediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.

Silvia Darin (S)

Pediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.

Elena Albertazzi (E)

Pediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.

Stefania Galimberti (S)

Center of Biostatistics for Clinical Epidemiology, University of Milano-Bicocca, Monza, 20900, Italy.

Eugenio Montini (E)

San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.

Andrea Calabria (A)

San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.

Maria Pia Cicalese (MP)

San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.
Pediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.
Università Vita-Salute San Raffaele, Milan, 20132, Italy.

Alessandro Aiuti (A)

San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy. aiuti.alessandro@hsr.it.
Pediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy. aiuti.alessandro@hsr.it.
Università Vita-Salute San Raffaele, Milan, 20132, Italy. aiuti.alessandro@hsr.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH